The 5 Best Remedies For Sinus Problems
SPECIAL FROM Here’s an appetizing tidbit: Your sinus produces one to two liters of mucus every day—that’s the size of two large soda bottles. Under normal conditions, most of the mucus dribbles undetected down your throat. Yes, it’s gross but also very important: Mucus filters out bacteria, viruses, and fungi in the air that we breathe, and moistens the nasal passages and sinuses, allowing us to breathe easier and lessen risk of infections. Sometimes, due to allergens, environmental pollution, nasal obstruction or inflammation, the system goes haywire, filling you with congestion. According...
Source: Healthy Living - The Huffington Post - March 26, 2016 Category: Consumer Health News Source Type: news
Intersect ENT wins expanded FDA approval for Propel Mini
Intersect ENT (NSDQ:XENT) said today it won FDA premarket approval for an expanded indication for its Propel mini steroid releasing sinus implant designed to treat patients undergoing frontal sinus surgery.
The expanded indication from the Menlo Park, Calif.-based company will allow the company to market the placement of the Propel mini in the frontal sinuses behind the eyebrows. Previous indication only allowed for placement in the ethmoid sinuses behind the bridge of the nose.
“This approval is significant for patients with frontal sinus disease, which has traditionally been difficult to treat and greatly impacts q...
Source: Mass Device - March 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Pre-Market Approval (PMA) Regulatory/Compliance Surgical Intersect ENT Inc. Source Type: news
Antifungals May Relieve Asthma, Chronic SinusitisAntifungals May Relieve Asthma, Chronic Sinusitis
A new protocol for testing the sputum of patients with asthma or chronic sinusitis for fungus could help select those who will benefit from antifungal therapies, research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2016 Category: Consumer Health News Tags: Allergy & Clinical Immunology News Source Type: news
Reslizumab Effective in Chronic Sinusitis With Nasal PolypsReslizumab Effective in Chronic Sinusitis With Nasal Polyps
For a subgroup of patients, an anti-interleukin-5 antibody improved asthma exacerbation rates, lung function, and quality of life, according to a subanalysis of data from two pivotal phase 3 trials. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 15, 2016 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Wound Infection and Sepsis Caused by
Arcanobacterium haemolyticum was first described in 1946 by MacClean et al. [cited in reference 1], who isolated it from U.S. servicemen and natives of the South Pacific. It is an unusual pathogen that occasionally causes wound infections, pharyngitis, sinusitis, and septicemia [2-7]. In addition, it has been documented as a rare cause of endocarditis and brain abscess [8,9], as well as the cause of a variety of zoonotic diseases [10]. Immunocompromised individuals or those with other underlying diseases [4] are most susceptible to developing A. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - March 5, 2016 Category: Microbiology Authors: Heather M. Smith, Inpamani Arul Tags: Case Report Source Type: news
Medical News Today: Sinus Infection Symptoms: Signs, Duration, Complications
Find out all about the symptoms of a sinus infection, also known as sinusitis. Sinus infection is one of the most commonly diagnosed infections in the US. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 4, 2016 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
New Drug Shows Promise Against Severe Sinusitis
Title: New Drug Shows Promise Against Severe SinusitisCategory: Health NewsCreated: 2/3/2016 12:00:00 AMLast Editorial Review: 2/4/2016 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - February 4, 2016 Category: Allergy & Immunology Source Type: news
New Drug Shows Promise Against Severe Sinusitis
In early trial, dupilumab helped treat nasal polyps that contribute to the illness (Source: WebMD Health)
Source: WebMD Health - February 3, 2016 Category: Consumer Health News Source Type: news
New Drug Shows Promise Against Severe Sinusitis
In early trial, dupilumab helped treat nasal polyps that contribute to the illness
Source: HealthDay
Related MedlinePlus Page: Sinusitis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 3, 2016 Category: Consumer Health News Source Type: news
Intersect ENT logs German reimbursement win
Intersect ENT (NSDQ:XENT) said today it clocked a German hospital reimbursement win from InEk, Germany’s Institute for Hospital Remuneration System, for its Propel sinus implant.
The propel device is a small steroid releasing implant designed to improve surgical outcomes for patients with chronic sinusitis undergoing ethmoid sinus surgery.
“We believe that the robust clinical evidence supporting Propel was key to this favorable decision, which we received on the 1st application round. While our focus as a company is very much on U.S. commercialization as well as development of our pipeline products, this repres...
Source: Mass Device - January 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Drug-Device Combinations Otolaryngology Ear, Nose & Throat Regulatory/Clearance Intersect ENT Inc. Source Type: news
Two startups win seed funding for pediatric med devices
The Philadelphia Pediatric Medical Device Consortium said today it issued 2 seed grants of $50,000 each to 2 medical device companies focused on pediatric care.
The 1st is Bellefonte, Penn.-based Actuated Medical, which is developing a device to reduce insertion force and needle slippage during bone biopsies and bone marrow aspiration procedures in children.
Because of the difference in size and curvature in children’s bones, traditional methods often have high rates of needle slippage and damage to surrounding tissue.
The 2nd company to win seed funding is Austin, Texas-based ENTvantage Diagnostics, which is dev...
Source: Mass Device - January 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Diagnostics Actuated Medical ENTvantage Diagnostics Philadelphia Pediatric Medical Device Consortium Source Type: news
Achoo! What You Need to Know About Colds vs. Allergies
Sujan Patel, MD Assistant Professor of Allergy and Immunology New York Eye and Ear Infirmary of Mount Sinai Achoo! What You Need to Know About Colds Versus Allergies Sneezing, sniffling, coughing... are these signs of a cold or allergy? Many symptoms of the common cold and respiratory allergies can overlap, leaving patients confused as to the best course of treatment. However, there are some simple ways to tell these conditions apart. Causes and treatments differ for each, so knowing which one you have could mean the difference between getting well soon or feeling ill for weeks. What Causes Colds and Allergies? The ...
Source: Healthy Living - The Huffington Post - December 14, 2015 Category: Consumer Health News Source Type: news
Chester's Jason Langton died from common sinusitis infection
Jason Langton, 20, from Blacon, Chester, was discovered semi-conscious on his bedroom floor with a lump on his head. An abscess - undetected by doctors - had formed on his brain. (Source: the Mail online | Health)
Source: the Mail online | Health - November 18, 2015 Category: Consumer Health News Source Type: news
Intersect ENT touts economic data from from Propel study
Intersect ENT (NSDQ:XENT) said today that budget impact data on its Propel steroid releasing implant for treating chronic sinusitis showed upfront costs offset by savings post-operatively.
The data was presented at the International Society for Pharmaeconomics and Outcomes Research annual meeting in Milan, Italy.
“A previous study demonstrated the use of Propel in sinus surgery for medically refractory chronic sinusitis may be a cost-effective intervention for preventing medical and surgical intervention following sinus surgery. This complementary analysis demonstrates the ‘affordability’ for a payor or self-fun...
Source: Mass Device - November 10, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Drug-Device Combinations Otolaryngology Ear, Nose & Throat Surgical Intersect ENT Inc. Source Type: news
Intersect ENT shares plummet on Q3 loss
Intersect ENT (NSDQ:XENT) yesterday released disappointing 3rd quarter earnings that fell well below Street expectations, sending shares plummeting.
Intersect ENT reported losses of $9.7 million, or 35¢ per share, on sales of $14.2 million for the 3 months ended September 30. That amounts to a 65.5% increase in losses on sales growth of 56.4% compared with the same period last year.
Wall Street analysts expected to see losses per share of 14¢, over 20¢ lower than Intersect ENT reported. Revenue was off Street expectations by $7 million.
Shares have fallen stiffly, dropping 26% to $16.06 as of 11:22 a.m. EST.
“Our...
Source: Mass Device - November 5, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Intersect ENT Inc. Source Type: news
